UNSPSC 51141552: Ethylphenacemide or pheneturide

This classification denotes an anticonvulsant agent with the molecular formula C11H14N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 878CEJ4HGX, chemically known as urea, (2-phenylbutyryl)- but generally known as ethylphenacemide, which bears US NIH Compound Identifier 72060. European Medicines Agency schedules Pheneturide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09760MIG.

The term PHENETURIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules ethylphenacemide in its Anatomical Therapeutic Chemical (ATC) Classification. Ethylphenacemide or pheneturide bears US NLM identifiers UMLS ID C0059837 and NCI Concept Code C72826. SMILES: CCC(C1=CC=CC=C1)C(=O)NC(=O)N.

UNSPSC 51141552 Ethylphenacemide or pheneturide is a Commodity code that shows minimal recent state and local procurement activity aligned with its nominal pharmaceutical scope. The single recent opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS—is explicitly for naloxone and drug deactivation systems, which falls outside the code's stated product scope and suggests a tagging misalignment rather than actual procurement under this commodity. State and local governments are not currently soliciting ethylphenacemide or pheneturide through posted competitive processes that the available records capture.

The Seminole County procurement, posted June 30, 2026 with a response deadline of July 26, 2023 (a date discrepancy within the source itself), sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB required electronic bid submission, drug-free workplace certification, E-Verify compliance, and specified workers' compensation, commercial general liability, and professional liability insurance. The contract included a two-year initial term with a one-year renewal option and a three-month probationary termination period, with potential FEMA funding introducing federal environmental compliance requirements. This opportunity does not represent meaningful market activity under the ethylphenacemide code itself; firms pursuing actual pharmaceutical procurement should monitor alternative UNSPSC classifications aligned with the specific drug or therapeutic category in question.